April 24, 2019 | Michael Easterling and Samantha Bonar
City of Hope’s bone marrow transplant program recently performed the procedure on its 15,000th patient, a remarkable milestone considering that the initiative started with just two physicians, three beds and guarded expectations in 1976.
Combined immunotherapy could tackle advanced cancers
April 15, 2019 | Zen Vuong
City of Hope physician-scientists recently opened two clinical trials to investigate a combination of cytokines and immunotherapy that may be able to transform nearly impossible-to-treat cancer into a disease that can be corralled into remission.
New Immunotherapy for Colon Cancer Answers a Patient's Prayer
December 24, 2018 | Maxine Nunes
After a CAT scan found a suspicious spot, a colonoscopy showed that Quiana Godinez had colon cancer. Godinez was put on the breakthrough immunotherapy drug Keytruda (pembrolizumab), which had just received FDA approval for certain types of cancers, including hers.
New hormone and immunotherapy trial for breast cancer patients
October 8, 2018 | City of Hope
This phase 2 trial studies the side effects and how well pembrolizumab and enobosarm work in treating patients with androgen receptor positive triple-negative breast cancer that has spread to other places in the body.
Live from ASCO: Immunotherapy Is a Revolution in Medicine
June 5, 2017 | Cary A. Presant, M.D.
Here at ASCO 2017 in Chicago, we’ve been hearing about promising new clinical trials that have shown that immunotherapy can control some of the most resistant cancers.